Delivery Order SPE2DB20D3101-SPE2DB25FRHK8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,131.01 to AmerisourceBergen Drug Corp for the supply of TREMFYA 100 mg/ml, a pharmaceutical product. This contract, awarded on May 27, 2025, with an ultimate completion date of May 28, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,320.48 to AmerisourceBergen Drug Corp for TREMFYA 100 MG/ML, a pharmaceutical product, with an ultimate completion date of September 5, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,720.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml, a pharmaceutical product, with an ultimate completion date of August 19, 2025. This competitive award, issued on August 18, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a $11,751.35 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of TREMFYA 100 mg/ml (one-press ml unit). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 20, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $8,962.95 to AmerisourceBergen Drug Corp for the supply of TREMFYA 200 mg/20 mL vials. This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with an ultimate completion date of August 20, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement vendor...
- The Defense Logistics Agency awarded a delivery order valued at $15,468.22 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. The contract, executed on August 25, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $14,539.40 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml syringes. This firm fixed-price delivery order, issued on September 18, 2025, with an ultimate completion date of September 19, 2025, represents a non-competitive procurement of a specialized pharmaceutical product. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its existing...
- The Defense Logistics Agency awarded a delivery order valued at $21,941.27 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml pharmaceutical supply on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL pharmaceutical product on July 14, 2025, with an ultimate completion date of July 15, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order valued at $42,826.81 to AmerisourceBergen Drug Corp for TREMFYA 100 mg/mL syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and will be performed at the vendor's Conshohocken, Pennsylvania location. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRHK8Delivery Order
The Defense Logistics Agency (DLA) awarded a $56,931.29 firm fixed price delivery order to AmerisourceBergen Drug Corp for TREMFYA 100 mg/ml injectable medication, with an ultimate completion date of April 22, 2025. This non-set-aside contract was competitively awarded and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for TREMFYA, a specialty injectable pharmaceutical, exemplifies the company's role in fulfilling federal medical supply needs across multiple therapeutic domains. AmerisourceBergen's prime IDC with DLA serves as a global pharmaceutical support vehicle enabling supply of brand-name and generic drugs, vaccines, specialty medications, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, positioning the company as a key vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $56.9k | 4/21/25 |